Dagmar Rosa-Bjorkeson's Net Worth
$1.23 Million
Who is Dagmar Rosa-Bjorkeson?
Dagmar Rosa-Bjorkeson has an estimated net worth of $1.23 Million. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS, INC., Xencor Inc, Mallinckrodt plc, and Baxalta Inc.
SEC CIK
Dagmar Rosa-Bjorkeson's CIK is 0001643934
Past Insider Trading and Trends
2015 was Dagmar Rosa-Bjorkeson's most active year for acquiring shares with 4 total transactions. Dagmar Rosa-Bjorkeson's most active month to acquire stocks was the month of May. 2023 was Dagmar Rosa-Bjorkeson's most active year for disposing of shares, totalling 5 transactions. Dagmar Rosa-Bjorkeson's most active month to dispose stocks was the month of May. 2015 saw Dagmar Rosa-Bjorkeson paying a total of $0.00 for 204,191 shares, this is the most they've acquired in one year. In 2023 Dagmar Rosa-Bjorkeson cashed out on 69,447 shares for a total of $501,429.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found
InvestorDagmar Rosa-Bjorkeson used to own units in Common Stock but no longer holds any shares there. From 2021 to 2023 Dagmar Rosa-Bjorkeson acquired a total of 26,391 shares in INTERCEPT PHARMACEUTICALS, INC., Dagmar also disposed a total of 26,391 shares of INTERCEPT PHARMACEUTICALS, INC. equalling to $501,429.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.39K |
$19.00 | -$501,429.00 |
0
|
Nov 8
| |||
Form 4
| +44.37% | 8.11K |
—
|
—
| 26.39K |
May 24
| |||
Form 4
| +73.39% | 7.74K |
—
|
—
| 18.28K |
May 25
| |||
Form 4
|
∞
| 10.54K |
—
|
—
| 10.54K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xencor Inc (XNCR) Snapshot price: $16.18
InvestorDagmar Rosa-Bjorkeson owns 10,993 units of Common Stock which is worth $177,866.74. From 2019 to 2024 Dagmar Rosa-Bjorkeson acquired a total of 10,993 shares in Xencor Inc.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +119.55% | 5.99K |
—
|
—
| 10.99K |
Jun 13
| |||
Form 4
|
∞
| 5.01K |
—
|
—
| 5.01K |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mallinckrodt plc (MNKTQ) Snapshot price: $0.04
Chief Strat & Corp Dev OfficerDagmar Rosa-Bjorkeson owns 23,431 units of Ordinary Shares which is worth $937.24. In the year 2018 Dagmar Rosa-Bjorkeson filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.04% | -246.00 |
$9.06 | -$2,228.76 | 23.43K |
Jun 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +41.47% | 6.58K |
$22.80 | -$24,236.40 | 22.43K |
Apr 1 - Apr 2
| |||
Form 4
| -1.53% | -247.00 |
$17.05 | -$4,211.35 | 15.85K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Baxalta Inc No price found
EVP and President, BiosimilarsDagmar Rosa-Bjorkeson used to own units in Common Stock, par value $0.01 per share but no longer holds any shares there. In the year 2015 Dagmar Rosa-Bjorkeson filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -71.29K |
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +25.11% | 14.28K |
$39.30 | -$38,592.60 | 71.14K |
Mar 3
| |||
Form 4/A
| -10.83% | -6.89K |
$34.63 | -$238,704.59 | 56.74K |
Dec 1
| |||
Form 4
| -37.25% | -6.89K |
$34.63 | -$238,704.59 | 11.61K |
Dec 1
| |||
Form 4
|
∞
| 62.97K |
—
|
—
| 62.97K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||